Private IO company developing unique approach to antigen-specific T cell therapy. Synthetic nanoparticles decorated w a combo of multiple tumor relevant antigens and co-stimulatory signals engaging directly w targeted T cells to orchestrate specific immune responses to cancer. Product applications as both SQ injectable and adoptively transferred cellular therapy. Multiple IND filings exp H1'19.
9119 Gaither Road
Gaithersburg, MD 20877
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.